GBIGBI is China’s leader in pharmaceutical and biotechnology data intelligence and consulting services. GBI provides in-depth analysis and insights that enable subscribers to stay ahead of China’s pharmaceutical, biotechnology and healthcare industries. Our offerings include: Weekly Roundup- free weekly updates on industry news; China Pharmaceutical & Biotechnology (CPB) Review – China’s premier monthly publication examining the latest industry trends; and SOURCE Information System- a data intelligence system adding value to every aspect of a pharmaceutical organization.
|
List of reports from GBI
|
$59.00
|
|
|
$5,000.00
|
|
|
$500.00
|
|
|
$5,000.00
|
|
|
$2,400.00
|
